CEACAM5 and neoplasm: A high clinical risk score has been developed toclarify the performance of laparos-copy prior to the resection, including variables, suchas the carcinoembryonic-antigen level, status of the primary-tumor lymphatic ganglion, thedisease lapse (from diagnosis to diagnosis of the hepatic metastasis), and the number andsize of the hepatic tumors.